CDSCO signals shift towards smarter, risk-based regulation to ease doing business for Indian pharma at…
CDSCO adopts risk-based approach to ease business for Indian pharma The News Mill Read the full…
CDSCO Advances Towards Risk-Based Regulatory Reforms for India's Pharma Sector Devdiscourse Read the full story at…
India’s Pharma Sector Must Go Beyond Generics, Pursue Greater R&D and Innovation: Piyush Goyal ddnews.gov.in Read…
Nifty Pharma Falls 0.46% on September 3 as the US Tariff Timeline Hangs Over India’s…
Indian Pharma Market Grows 10.7% in August Despite Volume Growth Losing Steam Medical Dialogues Read the…
Centre to support medical value travel, pharma, healthcare infra Medical Buyer Read the full story at…
Need to increase regulatory convergence to unlock investments, innovation in Pharma: Goyal pharma.economictimes.indiatimes.com Read the full…
India's Pharma Sector Must Go Beyond Generics, Pursue Greater R&D and Innovation: Piyush Goyal DD India…
From capacity to capability: Five proofs for India’s pharma future Express Pharma Read the full story…
